Feasibility of reaching populations at high risk for HIV in community pharmacies.

Autor:	Crawford ND; Department of Behavioral, Social and Health Education Sciences, Rollins School of Public Health, Emory University., Harrington KRV; Department of Medicine, School of Medicine, Emory University., Chandra C; Department of Epidemiology, Rollins School of Public Health, Emory University., Alohan DI; Department of Behavioral, Social and Health Education Sciences, Rollins School of Public Health, Emory University., Quamina A; National AIDS Education Services for Minorities., Beck O; Fielding School of Public Health, University of California Los Angeles., Young HN; Department of Clinical and Administrative Pharmacy, College of Pharmacy, University of Georgia.
Jazyk:	angličtina
Zdroj:	Journal of the American Pharmacists Association : JAPhA [J Am Pharm Assoc (2003)] 2024 Sep 04, pp. 102239. Date of Electronic Publication: 2024 Sep 04.
DOI:	10.1016/j.japh.2024.102239
Abstrakt:	Background: Growing evidence has shown feasibility for HIV prevention service integration in pharmacies, including HIV testing and screening for pre-exposure prophylaxis (PrEP). Yet, further work is needed to determine whether pharmacies can effectively reach those at increased risk of HIV transmission. Objectives: We aimed to describe the HIV risk profiles and willingness to obtain HIV prevention services of a sample of pharmacy clients. Methods: This was a cross-sectional pilot study aimed to develop a culturally appropriate pharmacy-based PrEP delivery model among Black men who have sex with men (MSM). Two pharmacies were recruited from low-income, underserved communities and participants were recruited within pharmacies for screener and social and behavioral surveys. Individuals were grouped by PrEP eligibility due to sexual risk, injection drug use risk, or both, and demographic and willingness measures were compared. Results: Among 460 pharmacy clients, 81 (17.6%) would have been eligible for PrEP due to sex or injection drug use risk. Most were eligible due to sexual risk (58.0%), while a substantial proportion were eligible due to injection drug use (27.2%) or a combination of sexual and injection drug use risk behaviors (42.0%). Of these eligible, median age was 31 years (IQR=28,32) and most had ≥1 female (75.3%) or male (96.3%) partner in the past 6 months. There was high willingness to receive a free HIV test in a pharmacy (90.1%). Most were willing to screen for PrEP in a pharmacy (95.1%) despite these services not being available in the state where this study was performed. There were no differences in willingness to obtain pharmacy-based HIV prevention services across risk groups. Conclusion: This study shows that pharmacies in disadvantaged areas can serve a key role in preventing and decreasing the transmission of HIV by reaching populations with high HIV burden and providing HIV prevention services. (Copyright © 2024. Published by Elsevier Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu